
Tenet Healthcare Corporation: updates and filings
Price
$291.54
November 16, 2026Market cap $23.2B
What Ploutos Investor adds for Tenet Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 29, 2026next Jan 28, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
September 2026
July 2026
April 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 29, 2026Results of operationsForm8-K
- Sep 22, 2026Material agreement entered, new material financial obligationForm8-K
- Sep 8, 2026Regulation FD disclosure, other material eventsForm8-K
- Sep 4, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 29, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 23, 2026Results of operationsForm8-K
- May 29, 2026Shareholder voteForm8-K
- Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 30, 2026Results of operationsForm8-K
- Apr 16, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 16, 2026Additional annual meeting materialFormDEFA14A
- Apr 16, 2026Annual meeting proxy statementFormDEF 14A
- Apr 10, 2026Officer or director changeForm8-K
- Mar 30, 2026Officer or director changeForm8-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 17, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 11, 2026Results of operationsForm8-K
- Feb 2, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Nov 24, 2025Officer or director changeForm8-K
- Nov 18, 2025Material agreement entered, new material financial obligationForm8-K
- Nov 5, 2025Material agreement entered, new material financial obligationForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 29, 2026 | 8-K | Results of operations | Document |
| Sep 22, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Sep 8, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Sep 4, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 29, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 23, 2026 | 8-K | Results of operations | Document |
| May 29, 2026 | 8-K | Shareholder vote | Document |
| Apr 30, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 30, 2026 | 8-K | Results of operations | Document |
| Apr 16, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 16, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 16, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 10, 2026 | 8-K | Officer or director change | Document |
| Mar 30, 2026 | 8-K | Officer or director change | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 17, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 11, 2026 | 8-K | Results of operations | Document |
| Feb 2, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Nov 24, 2025 | 8-K | Officer or director change | Document |
| Nov 18, 2025 | 8-K | Material agreement entered, new material financial obligation | Document |
| Nov 5, 2025 | 8-K | Material agreement entered, new material financial obligation | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Jan 14, 1994: every report, 8-K, meeting and letter. Of its other filings (1,141 in all), the newest.
The full analysis
What do Tenet Healthcare's filings show?
The filings are where every one of Tenet Healthcare's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.